Drug intelligence / Profile preview

Orovite

Development stage: Unknown
Lead developer: Thornton & Ross
Modality: Small Molecules
Administration: Oral

Overview

Orovite is a high-potency multivitamin supplement containing a specific combination of B-complex vitamins (thiamine, riboflavin, niacin, and pyridoxine) and Vitamin C (ascorbic acid). It is primarily used as a nutritional support during periods of illness, convalescence, or intense physical activity to reduce tiredness and fatigue and support immune function. Historically associated with companies like GSK and Thornton & Ross, it is marketed as an over-the-counter product rather than a prescription pharmaceutical.

Brand names: Orovite

Beyond the preview

Go deeper on Orovite.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orovite.

Explore the full profile